Search for: "In Re Antibiotic Antitrust Actions" Results 1 - 6 of 6
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Feb 2012, 5:49 pm by The Complex Litigator
(N.D.Ill. 1991) 761 F.Supp. 1320 [protective order limited discovery of information from plaintiff flight attendants to a representative sample of class members], and In re Antibiotic Antitrust Actions (S.D.N.Y. 1971) 333 F.Supp. 278 [states sought recovery for alleged overcharges in the sale of certain antibiotics], concerned the damages phase of a trial, not the liability phase. [read post]
5 Dec 2008, 1:00 pm
FDA issues draft guidance on submission of patent information for certain old antibiotics (FDA Law Blog) US: FDA publishes new guidance on contents of a complete submission for the evaluation of proprietary names (FDA Law Blog) USPTO appeals Wyeth v Dudas decision on patent term adjustment calculation; more patentees (including Molecular Insight and Biogen) follow Wyeth’s lead in seeking additional patent term adjustment (IP Updates) (Patent Docs) (Law360) (Patent Docs) (Law360)… [read post]
29 Aug 2012, 10:09 pm by FDABlog HPM
  The latest entrant to patent settlement agreement litigation is a Class Action Complaint filed in the U.S. [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA … [read post]